We are live on ! Find out more
PLC

Peapod Lane Capital Portfolio holdings

AUM $148M
1-Year Est. Return 89.92%
This Fund
S&P 500
This Quarter Est. Return
+27.69%
1 Year Est. Return
+89.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
+$26.3M
Cap. Flow
+$6.69M
Cap. Flow %
4.52%
Top 10 Hldgs %
32.18%
Holding
69
New
7
Increased
42
Reduced
12
Closed
8

Top Buys

Rank Stock Value
1
ENGN icon
enGene Therapeutics
ENGN
+$4.49M
2
PCYO icon
Pure Cycle
PCYO
+$2.04M
3
BCYC
Bicycle Therapeutics
BCYC
+$1.91M
4
BSET icon
Bassett Furniture
BSET
+$1.84M
5
FULC icon
Fulcrum Therapeutics
FULC
+$1.74M

Top Sells

Rank Stock Value
1
CVGI icon
Commercial Vehicle Group
CVGI
+$2.28M
2
FDMT icon
4D Molecular Therapeutics
FDMT
+$2.21M
3
FONR
Fonar
FONR
+$2.11M
4
TWIN icon
Twin Disc
TWIN
+$1.62M
5
KVHI icon
KVH Industries
KVHI
+$1.58M

Sector Composition

Rank Sector Weight
1 Industrials 21.12%
2 Healthcare 19.35%
3 Consumer Discretionary 16.44%
4 Real Estate 9.39%
5 Consumer Staples 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBLA
51
FB Bancorp
FBLA
$229M
$1.35M 0.91%
89,599
+1,401
+2% +$19.9K
GAIA icon
52
Gaia
GAIA
$39.4M
$1.35M 0.91%
640,797
+10,002
+2% +$25.8K
DCGO icon
53
DocGo
DCGO
$39.3M
$1.29M 0.87%
2,500,118
+1,370,924
+121% +$819K
LSBK icon
54
Lake Shore Bancorp
LSBK
$135M
$1.25M 0.84%
70,039
+1,096
+2% +$17.5K
AXR icon
55
AMREP Corp
AXR
$123M
$1.18M 0.8%
46,763
+701
+2% +$18.5K
FULC icon
56
Fulcrum Therapeutics
FULC
$294M
$1.05M 0.71%
+285,798
New +$1.74M
ZNTL icon
57
Zentalis Pharmaceuticals
ZNTL
$360M
$984K 0.66%
202,864
-164,004
-45% -$655K
SEER icon
58
Seer Inc
SEER
$110M
$739K 0.5%
445,450
+6,869
+2% +$12.5K
CLAR icon
59
Clarus
CLAR
$145M
$663K 0.45%
210,384
-320,487
-60% -$923K
MGX icon
60
Metagenomi Therapeutics
MGX
$45M
$625K 0.42%
525,024
+8,263
+2% +$11.1K
VIRC icon
61
Virco
VIRC
$93M
$384K 0.26%
+62,507
New +$379K
ANTX icon
62
AN2 Therapeutics
ANTX
$211M
– –
-59,854
Closed -$207K
AVIR icon
63
Atea Pharmaceuticals
AVIR
$430M
– –
-272,820
Closed -$1.44M
FDMT icon
64
4D Molecular Therapeutics
FDMT
$810M
– –
-241,480
Closed -$2.21M
FONR
65
DELISTED
Fonar
FONR
– –
-113,662
Closed -$2.11M
KZR
66
DELISTED
Kezar Life Sciences
KZR
– –
-126,692
Closed -$925K
TWIN icon
67
Twin Disc
TWIN
$333M
– –
-108,107
Closed -$1.62M
KYTX icon
68
Kyverna Therapeutics
KYTX
$518M
– –
-40,404
Closed -$336K
CLYM
69
Climb Bio
CLYM
$837M
– –
-108,878
Closed -$740K
1 2
3

Similar funds

VIS
Vertex Investment Solutions Chiyoda-Ku $148M AUM
SA
Sacks & Associates Warren, New Jersey $148M AUM
NCM
Nitor Capital Management Englewood Cliffs, New Jersey $148M AUM
PSB
Piscataqua Savings Bank Portsmouth, New Hampshire $148M AUM 32.61% 1-Year Est. Return
PPWM
Perissos Private Wealth Management Bethany, Oklahoma $148M AUM 24.7% 1-Year Est. Return
AAG
Accordant Advisory Group Annapolis, Maryland $148M AUM 23.8% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $148M AUM
MCM
Moon Capital Management New York $148M AUM 25.37% 1-Year Est. Return

Peapod Lane Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Peapod Lane Capital held 69 positions worth $148M, up 22% from $122M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Peapod Lane Capital deployed $6.69M of net new capital in Q2 2026, opening 7 new positions and adding to 42 existing holdings. Its largest new stake was enGene Therapeutics: 1,102,149 shares worth $1.91M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Commercial Vehicle Group, an estimated $2.28M trimmed.

  • Peapod Lane Capital's largest Q2 2026 buy was enGene Therapeutics: 1,102,149 shares worth $1.91M.
  • Peapod Lane Capital added most to Bicycle Therapeutics in Q2 2026, an estimated $1.91M increase.
  • Peapod Lane Capital's biggest Q2 2026 reduction was Commercial Vehicle Group, cutting an estimated $2.28M.
  • Peapod Lane Capital fully exited 4D Molecular Therapeutics in Q2 2026, selling an estimated $2.21M.
  • Peapod Lane Capital's ten largest holdings make up 32% of its $148M portfolio in Q2 2026.
  • Peapod Lane Capital opened 7 new positions and closed 8 in Q2 2026.
  • Peapod Lane Capital's portfolio value rose 22% quarter-over-quarter to $148M.

Based on Peapod Lane Capital's 13F filing for Q2 2026, filed 27 Jul 2026.